Dealing Together: Fighting Heart Disease and Obesity Simultaneously

Published Date: 14 Mar 2023

"You can't treat one of these conditions and ignore the others," says the author of the new review, explaining how obesity can affect the diagnosis and treatment of these heart conditions.

Read Full News

Latest News

Tips on Patient Communication in Dermatology, With Kassandra Holzem, MD Kassandra Holzem, MD

Holzem spoke in this interview about several additional highlights from her session at SDPA Fall regarding red flags in dermatology and when to admit from the clinic.

Key Skin Cancer Terms Not Understood by Almost 1/3 of Patients Surveyed

Key Skin Cancer Terms Not Understood by Almost 1/3 of Patients Surveyed

Apremilast Effective Treatment for Moderate to Severe Genital Psoriasis at 32 Weeks

Apremilast Effective Treatment for Moderate to Severe Genital Psoriasis at 32 Weeks

FDA Proposes Expanding Active Ingredient List for Sunscreens

FDA Proposes Expanding Active Ingredient List for Sunscreens

Discussing INTEGUMENT-INFANT and Roflumilast Cream 0.05% in Atopic Dermatitis, With Rocco Serrao, MD

Discussing INTEGUMENT-INFANT and Roflumilast Cream 0.05% in Atopic Dermatitis, With Rocco Serrao, MD

Mild to Moderate Psoriasis Linked with Indicators of Suboptimal Treatment, Disease Control

Mild to Moderate Psoriasis Linked with Indicators of Suboptimal Treatment, Disease Control

Todays Updates

Episode 156: Building Better Mood and Behavior Care for Parkinson Disease Marco Meglio, Sneha Mantri, MD, MS

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Sneha Mantri, MD, MS. [LISTEN TIME: 24 minutes]

FDA Approves Inebilizumab for AChR- and MuSK-Positive Generalized Myasthenia Gravis Isabella Ciccone, MPH

Inebilizumab is the first CD19-targeted B-cell therapy approved for antiAChR- or antiMuSK antibody–positive generalized myasthenia gravis, providing symptom control with twice-yearly dosing.

Weight-Adjusted Waist Index Can Predict CVD Risk in Cardiovascular Kidney Metabolic Syndrome

Weight-Adjusted Waist Index Can Predict CVD Risk in Cardiovascular Kidney Metabolic Syndrome

Todays Updates

Episode 156: Building Better Mood and Behavior Care for Parkinson Disease Marco Meglio, Sneha Mantri, MD, MS

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Sneha Mantri, MD, MS. [LISTEN TIME: 24 minutes]

FDA Approves Inebilizumab for AChR- and MuSK-Positive Generalized Myasthenia Gravis Isabella Ciccone, MPH

Inebilizumab is the first CD19-targeted B-cell therapy approved for antiAChR- or antiMuSK antibody–positive generalized myasthenia gravis, providing symptom control with twice-yearly dosing.

Weight-Adjusted Waist Index Can Predict CVD Risk in Cardiovascular Kidney Metabolic Syndrome

Weight-Adjusted Waist Index Can Predict CVD Risk in Cardiovascular Kidney Metabolic Syndrome

Latest News

Holzem spoke in this interview about several additional highlights from her session at SDPA Fall regarding red flags in dermatology and when to admit from the clinic.

Key Skin Cancer Terms Not Understood by Almost 1/3 of Patients Surveyed

Apremilast Effective Treatment for Moderate to Severe Genital Psoriasis at 32 Weeks

FDA Proposes Expanding Active Ingredient List for Sunscreens

Discussing INTEGUMENT-INFANT and Roflumilast Cream 0.05% in Atopic Dermatitis, With Rocco Serrao, MD

Mild to Moderate Psoriasis Linked with Indicators of Suboptimal Treatment, Disease Control

News All Time

sNDA for Ameluz-PDT as a Treatment for Superficial Basal Cell Carcinoma Submitted to FDA

sNDA for Ameluz-PDT as a Treatment for Superficial Basal Cell Carcinoma Submitted to FDA

INF904 Shows Strong Phase 2a Results in HS and CSU, With No Safety Signals

INF904 Shows Strong Phase 2a Results in HS and CSU, With No Safety Signals

Long-Term Course of HS Disease More Favorable Than Previous Estimates

Long-Term Course of HS Disease More Favorable Than Previous Estimates

Psoriasis Incidence Projected to Increase by 2025 Across Various Groups

Psoriasis Incidence Projected to Increase by 2025 Across Various Groups

How to Recognize and Treat Atopic Dermatitis in Patients with Skin of Color

How to Recognize and Treat Atopic Dermatitis in Patients with Skin of Color

Expert Consensus Provides Recommendations on Dermoscopy Standards for PAs

Expert Consensus Provides Recommendations on Dermoscopy Standards for PAs

Discussing Granuloma Annulare, Lichenoid Disorders, and Social Media, With Shannon Trotter, DO

Discussing Granuloma Annulare, Lichenoid Disorders, and Social Media, With Shannon Trotter, DO

Discussing New Topical Drugs for Atopic Dermatitis in Younger Patients, With Peter Lio, MD Peter Lio, MD

This Fall Clinical Dermatology Conference interview features Peter Lio, MD, discussing takeaways from several of his sessions at the meeting.

Lebrikizumab Benefits AD Patients With Skin of Color, With Vinay Mehta, MD Vinay Mehta, MD

New ACAAI 2025 data show lebrikizumab improves disease control, quality of life, and work productivity in patients of skin of color with moderate to severe atopic dermatitis.

Lebrikizumab Effectively Treats AD in Patients with Skin of Color, With Vinay Mehta, MD Vinay Mehta, MD

A phase 3b study in patients with skin of color found lebrikizumab provides reliable efficacy and safety for treating moderate-to-severe AD.

The Medical Sisterhood: Balance and Boundaries in the Holiday Season, With Angela Lamb, MD Mona Shahriari, MD, FAAD, Angela Lamb, MD

In this episode, the topic of navigating the holiday season and balancing a thriving medical career and a fulfilling family life are highlighted.

Skin of Color Savvy: Hair-Care Challenges in Dermatology, With Amy McMichael, MD, and Kayla Taylor, MD Amy McMichael, MD, Kayla Taylor, MD

This November 18 episode explores early detection, diagnosis, and management of scarring alopecias and hair-care–related hair loss in patients of color.

Non-Steroidal Topicals: A Game-Changer for Pediatric Atopic Dermatitis, With Emily Becker, MD Emily Becker, MD

Becker recapped hot topics of discussion during a recent HCPLive clinical forum.

AI’s Use in Non-Patient-Facing Dermatology Spaces, With Joseph Gatti, DMSc, MPAS, MBA, PA-C

AI’s Use in Non-Patient-Facing Dermatology Spaces, With Joseph Gatti, DMSc, MPAS, MBA, PA-C

Atopic Diseases Significantly Raise the Risk of Post-Surgical Complications

Atopic Diseases Significantly Raise the Risk of Post-Surgical Complications

Discussing Zasocitinib and Other TYK2 Inhibitors for Psoriasis, With Ronald Vender, MD Ronald Vender, MD

After his sessions on TYK2 Inhibitors for psoriasis and on palmoplantar pustulosis, Vender discussed several key insights in this interview.

Recommended News For You

Five new papers highlight cancer inequities, challenges and opportunities in South Asia

New CAR T-Cell Therapy Approved for Leukemia

According to research, the mineralization of the bone matrix controls the growth of tumor cells.

FDA Approves First Menin Inhibitor for Acute Leukemia

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

A Lot Can Be Said About You by Including Yourself in Photos.

While most cancer screenings won't prolong lives, there are still good reasons to continue screening.

Recommended Articles For You

Unmasking the Subtle Symptoms of Colon Cancer 

What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells 

Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer 

New Frontiers in Diagnosing and Managing Myelodysplastic Syndromes (MASLD) 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Ineffective medication can remove the "worst fear" of schizophrenia.

2.

Herpes virus-based vaccine shows promise in targeting tumors without side effects

3.

The pandemic had little impact on mental health symptoms.

4.

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

5.

Overdosing on Chemotherapy: A Single Gene Test Could Prevent Hundreds of Deaths Annually.

1.

Exploring the Potential of Xospata: A New Frontier in Cancer Treatment

2.

Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization

3.

ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer

4.

Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology

5.

Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy 

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

2.

Navigating the Complexities of Ph Negative ALL - Part XV

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot